The Pathology Department provides comprehensive diagnostic pathology services and carries out research involving the hematopoietic stem cell transplant population of the Seattle Cancer Care Alliance (SCCA). This includes pre-transplant patients, patients undergoing treatment currently and those in the long-term follow-up phase of treatment. Four pathologists from the Fred Hutch Clinical Division provide the interpretation and review of pathological material from SCCA patients in the Out-Patient Clinics at SCCA, the SCCA adult in-patient population at the University of Washington Medical Center (UWMC), and the SCCA pediatric in-patient population at Seattle Children’s. In addition, the four pathologists serve as consultants for other institutions worldwide by reviewing outside pathology cases. Services available through this laboratory include surgical Pathology, immunofluorescence, immunohistochemistry, special stains, and in-situ hybridization. SCCA pathologists also perform autopsies for adult and pediatric SCCA patients at UWMC.
Another role of the four Hutch pathologists associated with SCCA is their involvement in numerous research studies in the area of pathology of hematopoietic stem cell hematopoietic stem cell transplant transplants. This frequently involves collaboration with other members of the clinical faculty.
In addition, the SCCA Pathology Department accessions SCCA outpatient cytology and solid tissue tumor specimens for oncology patients, and prepares those specimens for transport to Harborview Medical Center and UWMC, respectively, for interpretation and storage at those facilities.